Mergers & Acquisitions
Nov. 12, 2013
Dealmakers
A roundup of weekly mergers & acquisitions and financing activity and the lawyers involved.
Latham counsels on $2.6 billion biotech sale
Latham & Watkins LLP represented San Diego-based drugmaker Santarus Inc. in its $2.6 billion sale to Salix Pharmaceuticals Ltd., a deal announced Nov. 7.
Salix, headquartered in Raleigh, N.C., was advised by Covington & Burling LLP.
Salix will pay Santarus shareholders $32 per share in cash, a 36 percent premium over the company's clo...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In